cas 1707563-96-9|| where to buy 1-(Oxetan-3-yl)-1H-1,2,3-triazole-4-carbaldehyde

Nom du produit:1-(Oxetan-3-yl)-1H-1,2,3-triazole-4-carbaldehyde

IUPAC Name:1-(oxetan-3-yl)-1H-1,2,3-triazole-4-carbaldehyde

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM292470-1g	in stock	Ɠȃƿ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1707563-96-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1707563-96-9; Formule moléculaire:C6H7N3O2; Point de fusion:-; Code SMILES:O=CC1=CN(C2COC2)N=N1; Densité:

: Numéro de catalogue:CM292470; Poids moléculaire:153.14; Point d'ébullition:; N° Mdl:; Stockage:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.